APOLLO HOSPITALS ENTER. L vs J B CHEMICALS AND PHARMA

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and J B CHEMICALS AND PHARMA (JBCHEPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

APOLLO HOSPITALS ENTER. L and J B CHEMICALS AND PHARMA are evenly matched on the numbers (77). The breakdown below shows where each one wins.

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

65.36
P/E ratio
54.51
13.42
P/B ratio
8.96
0.11%
Dividend yield
0.90%
₹135.04
EPS
₹44.19

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
18.90%
18.00%
Return on capital
25.00%
15.00%
EBITDA margin
27.00%
7.94%
Net margin
17.09%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
9.62%
33.39%
Profit CAGR (3Y)
20.03%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.27L Cr
Market cap
₹38,676 Cr
₹25,228 Cr
Revenue
₹4,148 Cr
₹2,003 Cr
Net profit
₹709 Cr
0.90
Debt / equity
0.00
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 77.8% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
J B CHEMICALS AND PHARMA
  • + ["Company has reduced debt.", "Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 40.3%", "Promoter holding has increased by 1.25% over last quarter."]
  • ["Stock is trading at 9.40 times its book value", "Promoter holding has decreased over last 3 years: -5.13%", "Working capital days have increased from 86.6 days to 126 days"]
APOLLO HOSPITALS ENTER. L full analysis J B CHEMICALS AND PHARMA full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.